Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

ePoster Display

225P - Prognostic factors of luminal A and luminal B intrinsic breast cancer subtypes of Croatian patients: A 5-year experience from Osijek

Date

16 Sep 2021

Session

ePoster Display

Topics

Tumour Site

Breast Cancer

Presenters

Raffaella Gudelj

Citation

Annals of Oncology (2021) 32 (suppl_5): S447-S456. 10.1016/annonc/annonc688

Authors

R. Gudelj1, J. Rajc2, M. Bakula3, R. Alaghehbandan4

Author affiliations

  • 1 Department Of Pathology And Forensic Medicine, Josip Juraj Strossmayer University of Osijek - Faculty of Medicine, 31000 - Osijek/HR
  • 2 Department Of Pathology And Forensic Medicine, Clinical Hospital Center Osijek, 31000 - Osijek/HR
  • 3 Department Of Pathology And Forensic Medicine, Clinical Hospital Center Osijek, Osijek/HR
  • 4 Department Of Pathology And Laboratory Medicine, University of British Columbia, Royal Columbian Hospital, Vancouver/CA

Resources

Login to access the resources on OncologyPRO.

If you do not have an ESMO account, please create one for free.

Abstract 225P

Background

Prognosis and treatment of breast cancers are associated with clinico-pathologic and biological characteristics of the tumor, which vary due to the heterogeneous nature of breast cancers. The aim of this study was to assess the frequency and prognostic parameters of luminal breast cancers among Croatian breast cancer population.

Methods

A large retrospective cross-sectional study including 1248 cases of primary breast cancer treated at Osijek University Hospital was conducted during 2016–2020. The clinico-pathologic and immunohistochemical (IHC) and in situ hybridization (ISH) data were extracted from pathology reports to study the luminal subtypes A and B. The cross-tabulated statistics of the observed characteristics were performed between the two subtypes.

Results

Luminal cancers comprised 89% (1006/1130) of the total number of cases. Of 1006 cases of luminal cancers, 717 cases (71.3%) were luminal B, while 289 (28.7%) were luminal A. Age profile of Luminal A and B cancers were similar (62.8 vs 62.7 years). Luminal B cancers were associated with higher grade (22.9% grade III in luminal B compared to 6.6% in luminal A), micorpapillary and metaplastic histology, and high frequency of nodal metastasis (39.8% in luminal B compared to 23.3% in luminal A).

Conclusions

Luminal B is the most frequent subtype of breast cancer in Croatian patients. They were associated with adverse clinico-histologic parameters such as higher grade and nodal metastasis. Our findings suggest that, despite lack of molecular studies in routine practice, IHC/ISH-based typing are sufficient for prognostic and therapeutic stratifications in breast cancers in Croatia.

Clinical trial identification

Editorial acknowledgement

Legal entity responsible for the study

The authors.

Funding

Has not received any funding.

Disclosure

All authors have declared no conflicts of interest.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.